151 related articles for article (PubMed ID: 1532507)
1. Goserelin (Zoladex) in the treatment of fibroids.
West CP; Lumsden MA; Baird DT
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():27-30. PubMed ID: 1532507
[No Abstract] [Full Text] [Related]
2. Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
West CP; Lumsden MA; Hillier H; Sweeting V; Baird DT
Hum Reprod; 1992 Mar; 7(3):328-32. PubMed ID: 1534089
[TBL] [Abstract][Full Text] [Related]
3. The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Van der Spuy ZM; Fieggan AG; Wood MJ; Pienaar CA
Horm Res; 1989; 32 Suppl 1():137-40. PubMed ID: 2533144
[TBL] [Abstract][Full Text] [Related]
4. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment with LHRH analogue Zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata.
Baird DT; Bramley TA; Hawkins TA; Lumsden MA; West CP
Horm Res; 1989; 32 Suppl 1():154-6. PubMed ID: 2533146
[TBL] [Abstract][Full Text] [Related]
6. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
McClelland HR; Quinn AJ
Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
[TBL] [Abstract][Full Text] [Related]
7. Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Maheux R; Lemay A; Blanchet P; Friede J; Pratt X
Hum Reprod; 1991 Apr; 6(4):500-5. PubMed ID: 1655823
[TBL] [Abstract][Full Text] [Related]
8. Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
Miller RM; Frank RA
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():37-41. PubMed ID: 1532509
[No Abstract] [Full Text] [Related]
9. Pretreatment with Zoladex improves surgery for uterine fibroids.
Oncology (Williston Park); 1991 Jan; 5(1):94. PubMed ID: 1828691
[No Abstract] [Full Text] [Related]
10. [Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Naether O; Diedrich K
Geburtshilfe Frauenheilkd; 1992 Feb; 52(2):121-2. PubMed ID: 1314757
[TBL] [Abstract][Full Text] [Related]
11. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
[TBL] [Abstract][Full Text] [Related]
12. Goserelin therapy before surgery for uterine fibroids.
Lumsden MA; West CP; Baird DT
Lancet; 1987 Jan; 1(8523):36-7. PubMed ID: 2879106
[No Abstract] [Full Text] [Related]
13. [New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
Gesenhues T; Hackenberg R; Diechert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():96-8. PubMed ID: 2522904
[TBL] [Abstract][Full Text] [Related]
14. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
Lumsden MA; West CP; Hawkins RA; Bramley TA; Rumgay L; Baird DT
J Endocrinol; 1989 May; 121(2):389-96. PubMed ID: 2526844
[TBL] [Abstract][Full Text] [Related]
15. Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy.
Maheux R; Lemay A
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():13-7. PubMed ID: 1532506
[No Abstract] [Full Text] [Related]
16. The place of Zoladex in deferred surgery for uterine fibroids. Zoladex Myoma Study Group.
Gerris J; Degueldre M; Peters AA; Romao F; Stjernquist M; al-Taher H
Horm Res; 1996; 45(6):279-84. PubMed ID: 8793522
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of LHRH analogue action in uterine fibroids.
Shaw RW
Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
[TBL] [Abstract][Full Text] [Related]
18. The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month.
Hackenberg R; Gesenhues T; Deichert U; Duda V; Schmidt-Rhode P; Schulz KD
Eur J Obstet Gynecol Reprod Biol; 1992 Jul; 45(2):125-9. PubMed ID: 1386817
[TBL] [Abstract][Full Text] [Related]
19. Uterine leiomyoma: treatment with LHRH agonist.
Maheux R; Lemay A
Prog Clin Biol Res; 1986; 225():297-311. PubMed ID: 3097669
[No Abstract] [Full Text] [Related]
20. [Myomectomy performed after Zoladex preparation with subsequent repair of the uterine wall via a balloon catheter in the uterine cavity].
Nikolov A; Raĭcheva R; Maĭnkhard K
Akush Ginekol (Sofiia); 1998; 37(1):55-7. PubMed ID: 9770805
[No Abstract] [Full Text] [Related]
[Next] [New Search]